Writing this as an informed medical consumer and also as a practicing pharmacist in North Carolina, I can attest to the effectiveness of EDTA IV chelation.
Having been discharged from a Tennessee hospital in February 2004 and refusing heart bypass from a physician who had never even seen my discharge papers from the hospital, I embarked on a program to lessen the coronary calcium at age 61. On Aug. 4, 2004, I went to the Northcross Diagnostic Imaging Center in Huntersville, N.C., where I had a calcium score of 846, which was quite high. This calcium score is a CT scan on the heart only. One year later, on Aug. 5, 2005, the calcium score was 622, which is a 224 difference, done at Fort Sanders West Diagnostic Center in Knoxville, Tenn. This was after about six months of IV chelation therapy and also a vegan diet. My arteries had begun to clear out.
I had not wanted the possible complications of bypass surgery, where the heart-lung blood circulation system and the surgery itself release a variety of debris, including bits of blood cells, tubing and plaques. For example, when surgeons clamp and connect the aorta to tubing, resulting emboli block blood flow and cause ministrokes. Other heart surgery factors related to mental damage may be events of hypoxia, high or low body temperature, abnormal blood pressure, irregular heart rhythms and fever after surgery.
Not wanting any of this is why I researched other procedures. Knowing that bypass operations can clog after five to eight years, on the average, if the patient does not change lifestyles and nutrition, I elected to change as much as I could. I also decided not to take statin drugs, as the side effects are quite dangerous, and physicians often do not recognize these side effects.
Following is the National Institutes of Health TACT Program results released in 2013, quite more recent than the 2000 JAMA article cited in previous letters [to the editor]: … “Overall, TACT showed that infusions of EDTA chelation therapy produced a modest but statistically significant reduction in cardiovascular events in EDTA-treated participants. However, further examination of the data showed that patients with diabetes were significantly impacted by chelation therapy while patients without diabetes were not.” (https://nccih.nih.gov/health/chelation)
Also, there are other methods of assisting revascularization of the heart, which use can be determined by cardiologists. … Each individual must make his or her own decision for their own health. I made my decision based on medical facts. Thank you.
— Kern Stafford, RPh